Article
Prevalence and clinicopathological correlation of BRAF V600E mutations in ameloblastoma: A PCR study from a tertiary centre in South India.
Journal of stomatology, oral and maxillofacial surgery - 1 Feb 2026
Jayamani Logeswari, Bottu Kavitha, Joseph Leena Dennis, Sekhar Ganthimathy
Abstract excerpt
BACKGROUND: Ameloblastoma is a locally aggressive, benign epithelial odontogenic tumor characterized by unpredictable biological behavior and a high recurrence rate. The recent WHO 5th edition classification (2022) has integrated key molecular advances, prominently featuring MAPK pathway mutations such as BRAF V600E. Understanding the prevalence with its clinicopathological associations with BRAF mutations is...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
